VIKING GLOBAL INVESTORS LP 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:01 pm Sale | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | VIKING GLOBAL INVESTORS LP | 2,118,284 4.700% | -893,000 (-29.66%) | Filing |
| 2021-02-12 7:52 pm Sale | 2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | VIKING GLOBAL INVESTORS LP | 3,011,284 7.400% | -1,432,000 (-32.23%) | Filing |